Torsemide description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Torsemide

Bryant Ranch Prepack
Bryant Ranch Prepack


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

TORSEMIDE DESCRIPTION




Torsemide
162043

CLINICAL PHARMACOLOGY


Mechanism of Action

++-



Pharmacokinetics and Metabolism

maxmaxmax















Clinical Effects























INDICATIONS & USAGE





TORSEMIDE CONTRAINDICATIONS




WARNINGS


Hepatic Disease With Cirrhosis and Ascites



Ototoxicity




Volume and Electrolyte Depletion







PRECAUTIONS

Laboratory Values


WARNINGS































Drug Interactions


















Carcinogenesis & Mutagenesis & Impairment Of Fertility




in vivoin vitro

Pregnancy




22

Labor & Delivery


Nursing Mothers


Pediatric Use





Geriatric Use


TORSEMIDE ADVERSE REACTIONS


contact Hetero Labs Limited at 866-495-1995 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.









Table 1. Reactions Possibly or Probably Drug-Related United States Placebo-Controlled Studies Incidence (Percentages of Patients)
 

Torsemide Tablets
(N=564)

Placebo
(N=274)

Headache

7.3

9.1
Excessive Urination 6.7
2.2
Dizziness
3.2
4.0
Rhinitis
2.8
2.2

Asthenia
2.0
1.5
Diarrhea
2.0
1.1
ECG Abnormality
2.0
0.4
Cough Increase
2.0
1.5
Constipation
1.8
0.7

Nausea
1.8

0.4
Arthralgia
1.8
0.7
Dyspespsia
1.6
0.7
Sore Throat
1.6
0.7
Myalgia
1.6
1.5
Chest Pain
1.2
0.4
Insomnia
1.2
1.8
Edema
1.1
1.1
Nervousness
1.1
0.4









Hypokalemia: See WARNINGS

Postmarketing Experience



i.e







DOSAGE & ADMINISTRATION


General


Congestive Heart Failure



Chronic Renal Failure



Hepatic Cirrhosis




Hypertension


HOW SUPPLIED






















Storage












contact Hetero Labs Limited at 866-495-1995 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Torsemide 10mg Tablet

Torsemide

Torsemide TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:63629-1346(NDC:31722-530)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
Torsemide TORSEMIDE 10 mg

Inactive Ingredients

Ingredient Name Strength
lactose monohydrate
cellulose, microcrystalline
CROSPOVIDONE
POVIDONES
MAGNESIUM STEARATE

Product Characteristics

Color Size Imprint Code Shape
WHITE 11 mm 57;H OVAL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:63629-1346-1 100 in 1 BOTTLE
2 NDC:63629-1346-2 30 in 1 BOTTLE

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA079234 2011-01-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.